- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Arrhythmia
The Practical Cardiology™ Arrhythmia clinical resource center provides information and insights for those interested in the latest from the field of heart rhythm disorders. From atrial fibrillation to ventricular tachycardia and everything in between, this page is where readers can find articles, videos, podcasts, and conference coverage related to arrhythmias and electrophysiology.
Despite Advances, Room for Improvement in Anticoagulation Exists for Older Adults
November 21, 2022
An analysis of data from Medicare beneficiaries receiving treatment over a decade-long period provides a snapshot of oral anticoagulation initiation and nonadherence among older patients with atrial fibrillation in the US.
Almost 1 in 3 High-Risk AFib Patients Not Receiving Anticoagulation
November 17, 2022
Using data from 88 medical centers across the US, new data is providing clinicians with an overview of contemporary trends in DOAC and warfarin use in adult patients with nonvalvular atrial fibrillation at high risk for stroke over the past decade.
Apixaban Trumps Other DOACs in Comparative Analysis of More than 500k AFib Patients
November 01, 2022
A comparative analysis leveraging EHR data from more than 500k new DOAC users from Europe and the US suggests apixaban use was associated with the lowest risk of gastrointestinal bleeding among agents within the class, with similar rates of thromboembolic events and mortality observed among the class.
Minority Patients with AFib Less Likely to Receive Oral Anticoagulation than White Counterparts
October 28, 2022
An analysis of the GWTG-Atrial Fibrillation Registry data suggests Black patients with AFib were 25% less likely to receive a prescription for oral anticoagulation at discharge and 27% less likely to receive a DOAC than their non-Hispanic White counterparts.
BMI in Childhood Could Signal AFib Risk Later in Life among Men
October 21, 2022
An analysis of data from linked national registries in Sweden provides clinicians with new insight into the impact of early life BMI on cardiovascular risk, particularly risk of atrial fibrillation, later in life among men.
Claims Data Compares Safety, Effectiveness of Apixaban vs Rivaroxaban in AFib and Valvular Heart Disease
October 18, 2022
An analysis of claims data from a 7-year period provides insight into the rate of ischemic stroke or systemic embolism and bleeding events with 2 popular DOACs in people with atrial fibrillation and valvular heart disease.
FDA Expands WATCHMAN FLX Approval to Include DAPT Option
September 06, 2022
Announced by Boston Scientific on September 6, the label for the WATCHMAN FLX LAAC device now includes a 45-day DAPT option as an alternative to the 45-day postprocedural OAC plus aspirin regimen for patients with nonvalvular atrial fibrillation.
Study Suggests Women More Likely to Develop AFib than Men When Accounting for Height and Weight
September 01, 2022
Despite the notion that men were at greater risk than women for developing AFib, new research indicates women were at a 49% greater risk of developing AFib than their male counterparts of the same height and weight.
Using Medical Marijuana for Chronic Pain Could Compromise Cardiovascular Health
August 22, 2022
An analysis of Danish national register data suggests patients using medical cannabis for pain had a 64% greater risk of arrhythmias than their unexposed counterparts.
SMART WARS: KardiaBand Bests Apple Watch Series 4 for Detecting Arrhythmia
July 07, 2022
Data from the SMART WARS study provides insight into the diagnostic utility of the KardiaBand and Apple Watch Series 4 devices for detecting arrhythmias in older adults.